Chemical Compound Review:
AC1LAD18 4-[3-(4-fluorophenyl)propyl]- 1,3-dimethyl...
Synonyms:
Gwaltney,
O'Connor,
Nelson,
Sullivan,
Imade,
Wang,
Hasvold,
Li,
Cohen,
Gu,
Tahir,
Bauch,
Marsh,
Ng,
Frost,
Zhang,
Muchmore,
Jakob,
Stoll,
Hutchins,
Rosenberg,
Sham,
Horvath,
Diano,
Leranth,
Garcia-Segura,
Cowley,
Shanabrough,
Elsworth,
Sotonyi,
Roth,
Dietrich,
Matthews,
Barnstable,
Redmond,
Bennasar,
Roca,
Ferrando,
Saporito,
Brown,
Miller,
Carswell,
Bryan-Lluka,
Siebert,
Pond,
Maroney,
Finn,
Connors,
Durkin,
Angeles,
Gessner,
Xu,
Meyer,
Savage,
Greene,
Scott,
Vaught,
Klein,
Kirby,
Freeborn,
Bloomquist,
- The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Ghilardi, M.F., Marx, M.S., Bodis-Wollner, I., Camras, C.B., Glover, A.A. Ann. Neurol. (1989)
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A. Basma, A.N., Heikkila, R.E., Nicklas, W.J., Giovanni, A., Geller, H.M. J. Neurochem. (1990)
- Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTP. Usuki, E., Van der Schyf, C.J., Castagnoli, N. Drug Metab. Rev. (1998)
- Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. Maroney, A.C., Finn, J.P., Connors, T.J., Durkin, J.T., Angeles, T., Gessner, G., Xu, Z., Meyer, S.L., Savage, M.J., Greene, L.A., Scott, R.W., Vaught, J.L. J. Biol. Chem. (2001)
- Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Horvath, T.L., Diano, S., Leranth, C., Garcia-Segura, L.M., Cowley, M.A., Shanabrough, M., Elsworth, J.D., Sotonyi, P., Roth, R.H., Dietrich, E.H., Matthews, R.T., Barnstable, C.J., Redmond, D.E. Endocrinology (2003)
- Probing the active sites of monoamine oxidase A and B with 1,4-disubstituted tetrahydropyridine substrates and inactivators. Palmer, S.L., Mabic, S., Castagnoli, N. J. Med. Chem. (1997)
- Evidence for nerve growth factor-potentiating activities of the nonpeptidic compound SR 57746A in PC12 cells. Pradines, A., Magazin, M., Schiltz, P., Le Fur, G., Caput, D., Ferrara, P. J. Neurochem. (1995)
- Partial GABAA receptor agonists. Synthesis and in vitro pharmacology of a series of nonannulated analogs of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol. Frølund, B., Kristiansen, U., Brehm, L., Hansen, A.B., Krogsgaard-Larsen, P., Falch, E. J. Med. Chem. (1995)
- Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes. Usuki, E., Pearce, R., Parkinson, A., Castagnol, N. Chem. Res. Toxicol. (1996)
- Regioselective 6-endo cyclizations of 2-indolylacyl radicals: total synthesis of the pyrido[4,3-b]carbazole alkaloid guatambuine. Bennasar, M.L., Roca, T., Ferrando, F. J. Org. Chem. (2006)
- Studies on the mechanism of MPTP oxidation by human liver monoamine oxidase B. Gessner, W., Brossi, A., Bembenek, M.E., Fritz, R.R., Abell, C.W. FEBS Lett. (1986)
- Parkinson-like syndrome in nonhuman primates receiving a tetrahydropyridine derivative. Barsoum, N.J., Gough, A.W., Sturgess, J.M., de la Iglesia, F.A. Neurotoxicology (1986)
- Selective azetidine and tetrahydropyridine formation via Pd-catalyzed cyclizations of allene-substituted amines and amino acids. Rutjes, F.P., Tjen, K.C., Wolf, L.B., Karstens, W.F., Schoemaker, H.E., Hiemstra, H. Org. Lett. (1999)
- Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Bryan-Lluka, L.J., Siebert, G.A., Pond, S.M. Naunyn Schmiedebergs Arch. Pharmacol. (1999)
- Potential antidepressant properties of SR 57746A, a novel compound with selectivity and high affinity for 5-HT1A receptors. Cervo, L., Bendotti, C., Tarizzo, G., Cagnotto, A., Skorupska, M., Mennini, T., Samanin, R. Eur. J. Pharmacol. (1994)
- 1-Methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine (MCTP): an alicyclic MPTP-like neurotoxin. Youngster, S.K., Saari, W.S., Heikkila, R.E. Neurosci. Lett. (1987)
- The interactions of monoamine oxidase with some derivatives of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sullivan, J.P., Tipton, K.F. J. Neural Transm. Suppl. (1990)
- Pharmacological properties of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: a potential visual marker for substrates of MPTP-induced neurotoxicity. Klein, B.G., Kirby, M.L., Freeborn, E.R., Bloomquist, J.R. Prog. Neuropsychopharmacol. Biol. Psychiatry (2001)
- Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors. Kalgutkar, A.S., Castagnoli, N. J. Med. Chem. (1992)
- CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito, M.S., Brown, E.M., Miller, M.S., Carswell, S. J. Pharmacol. Exp. Ther. (1999)
- Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency. Gwaltney, S.L., O'Connor, S.J., Nelson, L.T., Sullivan, G.M., Imade, H., Wang, W., Hasvold, L., Li, Q., Cohen, J., Gu, W.Z., Tahir, S.K., Bauch, J., Marsh, K., Ng, S.C., Frost, D.J., Zhang, H., Muchmore, S., Jakob, C.G., Stoll, V., Hutchins, C., Rosenberg, S.H., Sham, H.L. Bioorg. Med. Chem. Lett. (2003)